General information about company

Scrip code*500412
NSE Symbol*TIRUMALCHM
MSEI Symbol*NOTLISTED
ISIN*INE338A01024
Name of companyThirumalai Chemicals Limited
Type of companyMain Board
Class of securityEquity
Date of start of financial year01-04-2025
Date of end of financial year31-03-2026
Date of board meeting when results were approved14-02-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange10-02-2026
Description of presentation currencyINR
Level of roundingLakhs
Reporting TypeQuarterly
Reporting QuarterThird quarter
Nature of report standalone or consolidatedStandalone
Whether results are audited or unaudited for the quarter endedUnaudited
Whether results are audited or unaudited for the Year to date for current period ended/year endedUnaudited
Segment ReportingSingle segment
Description of single segmentChemical products and its intermediaries
Start date and time of board meeting14-02-2026 10:30
End date and time of board meeting14-02-2026 13:50
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualificationNot applicable
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?Yes
No. of times funds raised during the quarter2
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?NoNot Applicable



Financial Results – Ind-AS

Particulars3 months/ 6 months ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period01-10-202501-04-2025
Date of end of reporting period31-12-202531-12-2025
Whether results are audited or unauditedUnauditedUnaudited
Nature of report standalone or consolidatedStandaloneStandalone
Part IBlue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1Income
Revenue from operations30027110278
Other income7202494
Total income30747112772
2Expenses
(a)Cost of materials consumed1687268401
(b)Purchases of stock-in-trade639419013
(c)Changes in inventories of finished goods, work-in-progress and stock-in-trade1483-998
(d)Employee benefit expense 13774137
(e)Finance costs19685627
(f)Depreciation, depletion and amortisation expense8592589
(g)Other Expenses
1Project material and contract costs4015758
2Other expenses500215424
Total other expenses540321182
Total expenses34356119951
3Total profit before exceptional items and tax-3609-7179
4Exceptional items 00
5Total profit before tax-3609-7179
6Tax expense
7Current tax00
8Deferred tax-867-1722
9Total tax expenses-867-1722
10Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement00
11Net Profit Loss for the period from continuing operations-2742-5457
12Profit (loss) from discontinued operations before tax00
13Tax expense of discontinued operations00
14Net profit (loss) from discontinued operation after tax00
15Share of profit (loss) of associates and joint ventures accounted for using equity method00
16Total profit (loss) for period-2742-5457
17Other comprehensive income net of taxes-1785-2030
18Total Comprehensive Income for the period-4527-7487
19Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21Details of equity share capital
Paid-up equity share capital12061206
Face value of equity share capital11
22Reserves excluding revaluation reserve
23Earnings per share
iEarnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations-2.31-4.96
Diluted earnings (loss) per share from continuing operations-2.31-4.96
iiEarnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations00
Diluted earnings (loss) per share from discontinued operations00
iiiEarnings per equity share (for continuing and discontinued operations)
Basic earnings (loss) per share from continuing and discontinued operations-2.31-4.96
Diluted earnings (loss) per share from continuing and discontinued operations-2.31-4.96
24Debt equity ratioTextual Information( 1)
25Debt service coverage ratioTextual Information( 2)
26Interest service coverage ratioTextual Information( 3)
27Disclosure of notes on financial resultsTextual Information(4)

Other Comprehensive Income

Date of start of reporting period01-10-202501-04-2025
Date of end of reporting period31-12-202531-12-2025
Whether results are audited or unauditedUnauditedUnaudited
Nature of report standalone or consolidatedStandaloneStandalone
Other comprehensive income [Abstract]
1Amount of items that will not be reclassified to profit and loss
1Re-measurements of defined benefit plans16.00-54.00
2Equity instruments through other comprehensive income, net-2097.00-2322.00
3Income tax relating to items that will not be reclassified to profit and loss296.00346.00
Total Amount of items that will not be reclassified to profit and loss-1785.00-2030.00
2Income tax relating to items that will not be reclassified to profit or loss 0.000.00
3Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4Income tax relating to items that will be reclassified to profit or loss 0.000.00
5Total Other comprehensive income-1785.00-2030.00


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Mode of Fund RaisingPreferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds26-08-2025
Amount Raised45062.47
Report filed for Quarter ended31-12-2025
Monitoring AgencyApplicable
Monitoring Agency Name, if applicableCRISIL Limited
Is there a Deviation / Variation in use of funds raisedNo
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / VariationNot applicable
Comments of the Audit Committee after reviewNIL
Comments of the auditors, if anyNIL


Sr.Original ObjectModified Object, if anyOriginal AllocationModified allocation, if anyFunds UtilisedAmount of Deviation/Variation for the quarter according to applicable objectRemarks if any
1Investment in TCL global BV for onward investment eventually into TCL Specialties LLC in the United States of America to finance capital expenditureNIL330000330000
2General Corporate PurposesNIL11062.4711089.4711089.470
3Issue ExpensesNIL10009739730


Signatory Details

Name of signatoryRamya Bharathram
Designation of personManaging Director
PlaceChennai
Date14-02-2026


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (2)

Mode of Fund RaisingPreferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds23-12-2025
Amount Raised5613.99
Report filed for Quarter ended31-12-2025
Monitoring AgencyNot applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raisedNo
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / VariationNot applicable
Comments of the Audit Committee after reviewNIL
Comments of the auditors, if anyNIL


Sr.Original ObjectModified Object, if anyOriginal AllocationModified allocation, if anyFunds UtilisedAmount of Deviation/Variation for the quarter according to applicable objectRemarks if any
1Investment in TCL global BV for onward investment eventually into TCL Specialties LLC in the United States of America to finance capital expenditureNIL35993584.623584.620
2General Corporate PurposesNIL20002013.572012.590
3Issue ExpensesNIL1515.815.80